Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology and dermatology, a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical aesthetic devices and, through its majority ownership of Bausch + Lomb Corporation (Bausch + Lomb), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic area of eye health. Co.'s portfolio of products falls into five operating and reportable segments: Salix, International, Solta Medical, Diversified Products and Bausch + Lomb. We show 22 historical shares outstanding datapoints in our BHC shares outstanding history coverage, used to compute BHC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BHC market cap history over the course of time is important for investors
interested in comparing BHC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BHC versus a peer is one thing; comparing
BHC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BHC can fluctuate over the course of history.
With this page we aim to empower investors researching BHC by allowing them to research the BHC market cap history. |
Free BHC Email Alerts:
Video: The Importance of Market Cap
